Results 1 to 10 of about 656,251 (149)

Structural consensus among antibodies defines the antigen binding site. [PDF]

open access: yesPLoS Computational Biology, 2012
The Complementarity Determining Regions (CDRs) of antibodies are assumed to account for the antigen recognition and binding and thus to contain also the antigen binding site.
Vered Kunik, Bjoern Peters, Yanay Ofran
doaj   +4 more sources

The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites

open access: yesCurrent Research in Immunology, 2022
The antibody-binding Fc γ receptors (FcγRs) trigger life-saving immune responses and many therapeutic monoclonal antibodies require FcγR engagement for full effect. One proven strategy to improve the efficacy of antibody therapies is to increase receptor
Elizabeth A. Lampros   +6 more
doaj   +1 more source

Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site

open access: yesmAbs, 2020
LINGO-1 is a membrane protein of the central nervous system (CNS) that suppresses myelination of axons. Preclinical studies have revealed that blockade of LINGO-1 function leads to CNS repair in demyelinating animal models. The anti-LINGO-1 antibody Li81
Karl J. M. Hanf   +14 more
doaj   +1 more source

Sites responsible for infectivity and antigenicity on nervous necrosis virus (NNV) appear to be distinct

open access: yesScientific Reports, 2021
Nervous necrosis virus (NNV) is a pathogenic fish-virus belonging to the genus Betanodavirus (Nodaviridae). Surface protrusions on NNV particles play a crucial role in both antigenicity and infectivity.
Hyun Jung Gye, Toyohiko Nishizawa
doaj   +1 more source

Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray

open access: yesMicrobiology Spectrum, 2021
The rapid worldwide spread of SARS-CoV-2 has accelerated research and development for controlling the COVID-19 pandemic. A multi-coronavirus protein microarray was created containing full-length proteins, overlapping protein fragments of various lengths,
David Camerini   +22 more
doaj   +1 more source

Patterns of predicted T-cell epitopes associated with antigenic drift in influenza H3N2 hemagglutinin. [PDF]

open access: yesPLoS ONE, 2011
Antigenic drift allowing escape from neutralizing antibodies is an important feature of transmission and survival of influenza viruses in host populations.
E Jane Homan, Robert D Bremel
doaj   +1 more source

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.

open access: yesPLoS Pathogens, 2022
Exposure histories to SARS-CoV-2 variants and vaccinations will shape the specificity of antibody responses. To understand the specificity of Delta-elicited antibody immunity, we characterize the polyclonal antibody response elicited by primary or mRNA ...
Allison J Greaney   +10 more
doaj   +1 more source

A comparison of the binding sites of antibodies and single-domain antibodies

open access: yesFrontiers in Immunology, 2023
Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity. Antibodies (Abs) and single-domain antibodies (sdAbs) differ in the structures of their binding sites: most significantly, single-domain antibodies lack a light chain and
Gemma L. Gordon   +5 more
openaire   +3 more sources

GII.4 Human Norovirus: Surveying the Antigenic Landscape

open access: yesViruses, 2019
Human norovirus is the leading cause of viral acute onset gastroenteritis disease burden, with 685 million infections reported annually. Vulnerable populations, such as children under the age of 5 years, the immunocompromised, and the elderly show a need
Michael L. Mallory   +3 more
doaj   +1 more source

Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development. [PDF]

open access: yesPLoS Pathogens, 2013
Glycan masking is an emerging vaccine design strategy to focus antibody responses to specific epitopes, but it has mostly been evaluated on the already heavily glycosylated HIV gp120 envelope glycoprotein.
Sowmya Sampath   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy